Stabilizing After the Stabilization Period: What to Expect From Further Implementation of DSCSA

October 30, 2024  2:00–3:30 PM ET   Live Webinar   

Overview

As we approach the end of the Drug Supply Chain Security Act’s (DSCSA’s) stabilization period, FDA is beginning to implement DSCSA as part of its inspections, and is beginning to issue 483 observations relative to DSCSA. Join us to hear from legal, industry, and consultant panelists on this exigent topic, along with what to expect from inspections, compliance, and enforcement related to DSCSA as we move into this new era.

Speakers

Ilisa Bernstein
Read Bio
President, Bernstein Rx Solutions, LLC

Eric Garvin
Read Bio
Co-Founder, The LinkLab; Co-Founder, MediLedger

Rachael Hunt  
Read Bio
Senior Counsel, Regulatory Law, Pharmaceutical Quality, Johnson & Johnson

John McShane
Read Bio
Principal, Lachman Consultants

Moderated by Howard Sklamberg 
Read Bio
Partner, Arnold & Porter LLP

Buy Now

$199

Members

$299

Non-Members